Literature DB >> 16689611

Assessment instruments measuring malingering used with individuals who have mental retardation: potential problems and issues.

Kolleen E Hurley1, William Paul Deal.   

Abstract

Malingering, the exaggeration or fabrication of physical and/or psychological symptoms, can threaten the psychological assessment process (American Psychiatric Association, 2000). To enhance the validity of psychological evaluations, researchers have studied trends in malingering and developed instruments for its detection (Rogers, Bagby, & Dickens, 1992; Tombaugh, 1996). These instruments, however, may not be appropriate for individuals with significant subaverage intellectual functioning. Four instruments assessing malingering, frequently used in forensic evaluations, were administered to individuals with mental retardation. Results show that by utilizing established cut-off scores, we were able to classify a significant percentage of participants as "malingering," in spite of directions to perform optimally. Practical implications as well as directions for future research are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16689611     DOI: 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2

Source DB:  PubMed          Journal:  Ment Retard        ISSN: 0047-6765


  3 in total

1.  Prevalence and Assessment of Malingering in Homicide Defendants Using the Mini-Mental State Examination and the Rey 15-Item Memory Test.

Authors:  Wade C Myers; Ryan C W Hall; Marina Tolou-Shams
Journal:  Homicide Stud       Date:  2012-11-06

2.  Utility of the test of memory malingering (TOMM) in children ages 4-7 years with and without ADHD.

Authors:  Heather E Schneider; John W Kirk; E Mark Mahone
Journal:  Clin Neuropsychol       Date:  2014-09-23       Impact factor: 3.535

3.  [Response distortion or symptom severity? Symptom description by psychiatric patients and sociomedical assessment subjects].

Authors:  Maximilian Wertz; Eva Mader; Norbert Nedopil; Kolja Schiltz; Elena Yundina
Journal:  Nervenarzt       Date:  2020-12-18       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.